Answers are grounded in this paper and cite their sources.
Review summarizes synthesis methods and diverse applications of gold nanoparticles in biomedicine, indicating significant potential.
Gold nanoparticles (AuNPs) exhibit exceptional physicochemical properties, notably localized surface plasmon resonance (LSPR), enabling diverse applications in biomedicine, molecular imaging (CT/PAI/MRI), photothermal therapy (PTT), and targeted drug delivery. This review systematically examines synthesis strategies, emphasizing pulsed laser ablation in liquid (PLAL) as a surfactant-free, eco-friendly “top-down” method producing pristine 5–50 nm AuNPs via plasma plume confinement and cavitation-induced nucleation. Complementary “bottom-up” green biosynthesis leverages plant/fruit extracts (polyphenols/flavonoids), microorganisms, and fungi (nitrate reductase) to yield biofunctionalized AuNPs (10–80 nm) with inherent stability for theranostics. Comparative analyses highlight PLAL’s superiority in purity/yield compared to chemical methods, while biological methods excel in scalability and multifunctionality. Shape-dependent plasmonic heating: nanorods achieve ΔT = 45–55 °C vs. spheres (25 °C), underpinning PTT efficacy. The review elucidates targeting strategies (passive EPR vs. active ligand-receptor), hybrid imaging, and challenges, including EPR heterogeneity, synthesis reproducibility, and clinical translation. Future directions prioritize fs-PLAL optimization, biohybrid architectures, and multimodal AuNP platforms for precision oncology.
No takes yet. Share an insight, caveat, or question.
Rahman et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: